Brain tumor vaccine shows promise

A new vaccine for glioblastoma is showing promise in early trials. The vaccine, called SurVaxM, targets proteins found in the tumor. Early trials report that life expentacys were extended from 12 to 18 months to 26 months on average. Phase 2 results will be available in mid-2024.

Biden admin finalizes deal preserving preventative care

This week, the Biden administration finalized a deal under the Affordable Care Act (ACA) that requires health insurers to cover preventative care like cancer screenings and HIV preventatives at no extra cost. The ruling does not cover services the federal task force recommended before 2010.

Is nut consumption linked to longevity?

Researchers found that consuming 60 grams of mixed nuts per day increased verbal memory and blood flow to the brain. Experts believe nuts lower inflammation in the brain. Walnuts, which have omega-3 fatty acids, antioxidants, showed the best results.